Intraoperative 3D Longitude-Latitude-Depth Localization vs CT-Guided Lung Localization for Small Peripheral Nodules
Official title: Intraoperative Longitude-Latitude-Depth Three-Dimensional Localization Versus Preoperative CT-Guided Percutaneous Lung Puncture Localization for the Treatment of 0.8-2 cm Peripheral Pulmonary Nodules: A Multicenter, Randomized, Open-Label, Non-Inferiority Clinical Trial
Run by Qilu Hospital of Shandong University · NCT07675889 · Data updated 2026-11-12
This study tests whether intraoperative 3D longitude–latitude–depth localization can identify 0.8–2 cm peripheral lung nodules as reliably as the standard preoperative CT-guided localization in adults undergoing VATS surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 274 (estimated) |
| Sponsor | Qilu Hospital of Shandong University Academic / other |
| Locations | 4 sites (Xingyi, Guizhou and 3 other locations) |
| Status | Recruiting |
| Started | July 1, 2026 |
| Main results expected | July 1, 2028 |
| Study ends | July 1, 2028 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT07675889 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 with a single 0.8–2 cm peripheral pulmonary nodule suitable for VATS sublobar resection and no contraindications to localization procedures.
✕Probably not a fit
Patients with nodules not easily localized by intraoperative methods or with contraindications to surgery or localization may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized-like comparison evaluates two localization methods for small peripheral pulmonary nodules in adults undergoing video-assisted thoracoscopic sublobar resection. The primary aim is to determine if intraoperative longitude-latitude-depth localization is non-inferior to preoperative CT-guided percutaneous localization in achieving accurate nodule localization. Secondary goals include assessing perioperative outcomes such as time to localize, recovery metrics, pain, quality of life, and complication rates. The study uses anatomical landmarks and imaging measurements to estimate nodule position intraoperatively, potentially reducing preoperative procedures and related risks. Eligible participants are adults aged 18–80 with a single peripheral 0.8–2 cm pulmonary nodule suitable for VATS sublobar resection, with no contraindications to localization or surgery.
Why it matters
Potential benefit: If successful, patients may benefit from accurate nodule localization with fewer preoperative procedures and related risks, potentially shorter recovery times and preserved lung tissue.
How similar studies have gone: Prior approaches using preoperative localization are established; this intraoperative 3D method is novel and its success is yet to be demonstrated in widespread practice.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinically diagnosed pulmonary nodule by non-contrast chest CT. * Age 18 to 80 years. * Expected survival time of at least 12 months. * Single peripheral pulmonary nodule with a diameter between 0.8 cm and 2 cm. * Chest CT characteristics meeting both of the following criteria: 1. Solid component proportion ≤50%. 2. Located subpleurally or in the outer one-third of the lung parenchyma. * Willing to undergo VATS-assisted sublobar resection. * No contraindications to pulmonary localization procedures or surgery. * Able to understand the study and willing to sign written informed consent. Exclusion Criteria: * Use of other localization methods or other surgical procedures. * Concurrent participation in another clinical study. * Pregnancy. * Unwillingness or inability to cooperate with participation in this study for any reason.
Where it's running
-
Xingyi People's Hospital
Xingyi, Guizhou, China Recruiting -
Ningxia Hui Autonomous Region People's Hospital
Yinchuan, Ningxia, China Recruiting -
Qilu Hospital of Shandong University
Jinan, Shandong, China Recruiting -
Linqing People's Hospital
Linqing, Shandong, China Recruiting
Study contacts
- Study coordinator: Zhenguo Sun, Doctor of Medicine (MD)
- Email: sunzg@sdu.edu.cn
- Phone: +86-185-6008-9136
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted longitudinal CT to guide indeterminate lung nodules
This trial tests whether giving doctors an AI report that tracks nodules over serial CT scans helps reduce unnecessary benign lung resections in patients with indeterminate nodules.
-
3D airway mapping guides double-lumen tube sizing for thoracic surgery
This study tests whether 3D airway reconstruction helps choose the best double-lumen breathing tube size for adults undergoing thoracic surgery.
-
Making a digital twin of the lung using photon-counting chest CT and clinical data
This project will try to use adults' clinical records and non-contrast photon-counting chest CT scans to find lung nodules, tumors, and other lung diseases and to build a virtual 'digital twin' of the lung.
-
PET scan targeting CDH3 for lung tumors
This will test whether a new PET imaging agent called 68Ga-TOI-1 that targets CDH3 can better detect and stage lung tumors and help tell malignant from benign pulmonary nodules in adults with suspected or confirmed non-small cell lung cancer.
-
Stopping smoking before bronchoscopy or CT‑guided lung biopsy
This project tests whether offering immediate quit-smoking support and measuring nicotine markers helps people who smoke and are having a bronchoscopy or CT‑guided lung biopsy stop smoking.
-
Nerve block comparison for CT-guided lung nodule localization: retro‑SCTLB versus TPVB
This trial will try two ultrasound-guided nerve blocks—retro‑SCTLB and thoracic paravertebral block (TPVB)—to see which gives wider local anesthetic spread and sensory numbness for adults having CT‑guided lung nodule localization.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.